Thus, identifying tumor-specific CTLs solely using IFNγ-based techniques might overlook a large fraction of antigen-specific T cells and could generate unexpected biases in analyses, especially during ex vivo evaluation of anti-tumor responses from TILs. Here, IFNG is linked to neoplasm.